| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/09/2009 | WO2009044883A1 Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient |
| 04/09/2009 | WO2009044854A1 Granule, tablet, and their production methods |
| 04/09/2009 | WO2009044803A1 Process for producing product of asymmetric-catalyst michael reaction |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044787A1 Remedy for tendon rupture disease comprising tenomodulin as the active ingredient |
| 04/09/2009 | WO2009044777A1 Oxazolidinone derivative having 7-membered hetero ring |
| 04/09/2009 | WO2009044765A1 Novel chondroitin sulfate having decreased molecular weight and use thereof |
| 04/09/2009 | WO2009044548A1 Antidiarrhetic composition, product containing the same and method of preventing diarrhea |
| 04/09/2009 | WO2009044547A1 Nerve cell death inhibitor |
| 04/09/2009 | WO2009044423A1 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid |
| 04/09/2009 | WO2009044402A1 Endocannabinoids for enhancing growth and development in infants |
| 04/09/2009 | WO2009044380A2 Formulations containing orlistat particles having controlled particle size |
| 04/09/2009 | WO2009044311A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| 04/09/2009 | WO2009044294A2 Means and methods for the treatment of cataract and presbyopia |
| 04/09/2009 | WO2009044251A2 Hydrocortisone derivatives and use thereof for therapeutic or cosmetic indications |
| 04/09/2009 | WO2009044250A1 New compounds as adenosine a1 receptor antagonists |
| 04/09/2009 | WO2009044241A1 The method of treatment or prophylaxis of an arbovirus infection using oil composition derived from a melaleuca plant |
| 04/09/2009 | WO2009044211A1 Process for the preparation of zolmitriptan, salts and solvates thereof |
| 04/09/2009 | WO2009044202A1 Compounds and methods for pharmaceutical use |
| 04/09/2009 | WO2009044200A1 Steroidal [3, 2-c] pyrazole compounds, with glucocorticoid activity |
| 04/09/2009 | WO2009044162A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
| 04/09/2009 | WO2009044160A1 Pyridine derivatives for the treatment of amyloid-related diseases |
| 04/09/2009 | WO2009044153A2 Inhibitors and uses |
| 04/09/2009 | WO2009044147A1 Indolizine derivatives with crth2 receptor affinity for the treatment of inflammatory diseases |
| 04/09/2009 | WO2009044141A1 Compositions comprising cetirizine and a non beta-2-adrenoreceptor agonist, a beta-2-adrenoreceptor agonist or an anti -inflammatory and the use thereof for the treatment of respiratory disorders |
| 04/09/2009 | WO2009044134A1 Indolizine derivatives with crth2 receptor affinity for the treatment of inflammatory diseases |
| 04/09/2009 | WO2009044127A1 Therapeutic use of diaminophenothiazines |
| 04/09/2009 | WO2009044019A2 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/09/2009 | WO2009044018A2 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 04/09/2009 | WO2009044011A2 Use of at least one oxime derivative of 3,5-seco-4-norcholestane as antioxidants |
| 04/09/2009 | WO2009044010A2 Use of at least one oxime derivative of cholest-4-en-3-one as antioxidants |
| 04/09/2009 | WO2009044009A2 Use of 4-azacholest-4-ene n-oxide or derivatives thereof as antioxidants |
| 04/09/2009 | WO2009044007A2 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/09/2009 | WO2009044006A2 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid the pharmaceutically-acceptable esters and salts and solvates thereof for use as medicament |
| 04/09/2009 | WO2009043987A1 Antibiotic compositions containing essential oils, prophylaxis and treatment of nosocomial diseases |
| 04/09/2009 | WO2009043986A1 Three-functional pseudo-peptidic reagent, and uses and applications thereof |
| 04/09/2009 | WO2009043956A1 Taxane pharmaceutical formulation |
| 04/09/2009 | WO2009043934A1 IMIDAZO[L,2-α]QUINOXALINES AND DERIVATIVES THEREOF FOR TREATING CANCERS |
| 04/09/2009 | WO2009043926A2 Oral fast disintegrating tablets |
| 04/09/2009 | WO2009043914A1 Multi particulate matrix system containing galantamine |
| 04/09/2009 | WO2009043902A1 Bisbenzimidazoles as antimalarial agents |
| 04/09/2009 | WO2009043890A1 Oxadiazole diaryl compounds |
| 04/09/2009 | WO2009043889A2 Oxadiazole derivatives |
| 04/09/2009 | WO2009043884A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors |
| 04/09/2009 | WO2009043883A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors |
| 04/09/2009 | WO2009043844A2 Orodispersible tablets |
| 04/09/2009 | WO2009043836A1 A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases. |
| 04/09/2009 | WO2009043834A1 Pharmaceutical compositions of 5-hydr0xytrypt0phan and serotonin-enhancing compound |
| 04/09/2009 | WO2009043797A2 Salts of a cgrp antagonist, method for producing the same and use thereof as drugs |
| 04/09/2009 | WO2009043784A1 Cyclopropyl aryl amide derivatives and uses thereof |
| 04/09/2009 | WO2009043780A1 Tetrazole-substituted aryl amide derivatives and uses thereof |
| 04/09/2009 | WO2009043747A2 N-heterocyclic biaryl carboxamides as ccr receptor antagonists |
| 04/09/2009 | WO2009043593A1 Combination therapy using memantine and glitazones |
| 04/09/2009 | WO2009043582A1 Nicotinamide n-oxide derivatives as vanilloid-1 receptor modulators |
| 04/09/2009 | WO2009043577A2 Contraceptive 19-nor progesterones |
| 04/09/2009 | WO2009043538A1 Artemisinin derivatives for the treatment of melanoma |
| 04/09/2009 | WO2009043495A1 Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid n-phenylamides in the treatment of pain |
| 04/09/2009 | WO2009043355A2 SYSTEMIC PRO-HEMOSTATIC EFFECT OF SYMPATHICOMIMETICS WITH AGONISTIC EFFECTS ON α-ADRENERGIC AND/OR β-ADRENERGIC RECEPTORS OF THE SYMPATHETIC NERVOUS SYSTEM, RELATED TO IMPROVED CLOT STRENGTH |
| 04/09/2009 | WO2009043354A2 Combination treatment for the treatment of hepatitis c virus infection |
| 04/09/2009 | WO2009043353A2 Micromirs |
| 04/09/2009 | WO2009043320A2 Substituted 6-(alkylbenzylamino)purine derivatives for use as cytokinin receptor antagonists and preparations containing these derivatives |
| 04/09/2009 | WO2009043319A1 Preparation for wound healing and prevention of bandage adhesion to the wound, containing chitosan-glucan |
| 04/09/2009 | WO2009043307A1 Medicine composition containing abafungin |
| 04/09/2009 | WO2009043296A1 Gambogic glycoside derivatives and analogs, the preparation and the application thereof |
| 04/09/2009 | WO2009043226A1 A stable liquid composition comprising taxan derivatives and its preparation method. |
| 04/09/2009 | WO2009043136A1 Improving the energy status of an individual by enhanced usage of an endogenous fuel source |
| 04/09/2009 | WO2009043117A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | WO2009043114A1 Arsenoxide compound and method of use |
| 04/09/2009 | WO2009043111A1 Composition and method for dermal regeneration |
| 04/09/2009 | WO2009043093A1 Hif inhibition |
| 04/09/2009 | WO2009026227A3 Highly selective sigma receptor ligands |
| 04/09/2009 | WO2009026179A3 Antiinfective proanthocyanidin compounds and methods of use thereof |
| 04/09/2009 | WO2009024821A3 Oxadiazole derivatives as dgat inhibitors |
| 04/09/2009 | WO2009024325A3 Treatment of sleep disorders |
| 04/09/2009 | WO2009024324A3 Treatment of sleep disorders |
| 04/09/2009 | WO2009023761A3 Pharmaceutical compositions comprising ropinirole |
| 04/09/2009 | WO2009023434A3 Method for stabilizing phenylephrine |
| 04/09/2009 | WO2009023416A3 Cosmetic methods and compositions for repairing human skin |
| 04/09/2009 | WO2009023267A3 Methods for modulating development and expansion of il-17 expressing cells |
| 04/09/2009 | WO2009023253A3 IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO |
| 04/09/2009 | WO2009022821A3 Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same |
| 04/09/2009 | WO2009022354A3 Modified dosage forms of tacrolimus |
| 04/09/2009 | WO2009022311A3 1,2-diamido-ethylene derivatives as orexin antagonists |
| 04/09/2009 | WO2009021868A3 Novel piperazine amide derivatives |
| 04/09/2009 | WO2009021235A3 Methods and compositions for treating cancer |
| 04/09/2009 | WO2009021083A8 Quinoxaline derivatives as pi3 kinase inhibitors |
| 04/09/2009 | WO2009020521A3 Identification and treatment of estrogen responsive prostate tumors |
| 04/09/2009 | WO2009019607A3 Beta adrenergic receptor ligand derivatives for modulating apoptosis |
| 04/09/2009 | WO2009019599A3 Extended release compositions comprising tolterodine |
| 04/09/2009 | WO2009019472A4 1, 2, 4 -triazole derivatives as serotonergic modulators |
| 04/09/2009 | WO2009017777A3 Metabolites and derivatives of ambrisentan |
| 04/09/2009 | WO2009016286A3 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
| 04/09/2009 | WO2009016218A3 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
| 04/09/2009 | WO2009013596A3 Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products |
| 04/09/2009 | WO2009013475A3 Methods and products for improving wound healing |
| 04/09/2009 | WO2009013171A3 Heterocyclic antiviral compounds |
| 04/09/2009 | WO2009012784A3 Methods for preparing cytotoxic complexes of emulsifier and fatty acid |
| 04/09/2009 | WO2009007535A3 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 04/09/2009 | WO2009007137A3 Pharmaceutical composition for topical application of poorly soluble compounds |
| 04/09/2009 | WO2009006311A3 Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals |